VCYT
Veracyte, Inc.
NasdaqGMUSDEQUITY
Healthcare
DELAYED
Buy
+36/100
Last price
44.91
▼ 2.76 (5.79%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
48.02
Prev close
47.67
Day high
48.84
Day low
44.09
Volume
1.73M
Market cap
$3.59B
P/E (TTM)
34.08
52W range
29.46 – 60.91
Day trading desk
Gap from prior close
+0.73%
Prior close 47.67
VWAP
44.98
-0.16% from price
Relative volume
2.24×
Unusually busy
Session range
10.78%
44.09 – 48.84
Position in range
17%
Near session low
ATR (14D)
2.74
6.10% of price
Prior day high
47.78
PDH
Prior day low
45.00
PDL
Bid / ask spread
—
Quote not published
Session volume
3.01M
Avg 1.34M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-3.10%
-5.1%
1M
+4.98%
+3.8%
3M
-20.44%
-25.0%
6M
+38.88%
+20.7%
YTD
+6.06%
-8.2%
1Y
+24.03%
+7.6%
3Y
+99.96%
+17.7%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on VCYT open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+10.86K
Net buying
Buy transactions
11
248.45K shares
Sell transactions
14
237.59K shares
Net transactions
+25
Buys less sells
Sell : buy shares
1.0 : 1
Mixed
Insider-held shares
396.33K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 21, 26 | LEITE JOHN Officer |
SELL | 4.01K | $160.60K | Direct |
| Sep 14, 26 | HOLSTEIN JENS Director |
SELL | 5.00K | $204.75K | Direct |
| Sep 4, 26 | CHAMBERS REBECCA Chief Financial Officer |
SELL | 3.65K | $157.39K | Direct |
| Sep 4, 26 | MCGUIRE ANNIE General Counsel |
SELL | 3.25K | $140.21K | Direct |
| Sep 4, 26 | FEBBO PHILLIP G Officer |
SELL | 13.11K | $564.41K | Direct |
| Sep 1, 26 | BHANJI MUNA Director |
SELL | 1.86K | $80.10K | Direct |
| Jun 18, 26 | EASTHAM KARIN Director |
SELL | 3.73K | $197.23K | Direct |
| Jun 11, 26 | EASTHAM KARIN Director |
STOCK | 5.27K | $0 | Direct |
| Jun 11, 26 | JONES EVAN Director |
STOCK | 5.27K | $0 | Direct |
| Jun 11, 26 | EPSTEIN ROBERT S Director |
STOCK | 5.27K | $0 | Direct |
| Jun 11, 26 | SHAFER DAVID BRENT Director |
STOCK | 5.27K | $0 | Direct |
| Jun 11, 26 | HOLSTEIN JENS Director |
STOCK | 5.27K | $0 | Direct |
| Jun 11, 26 | BHANJI MUNA Director |
STOCK | 5.27K | $0 | Direct |
| Jun 11, 26 | BARR ELIAV Director |
STOCK | 5.27K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BARR ELIAV |
Director | 56.46K | Stock Award(Grant) |
BHANJI MUNA |
Director | 42.72K | Sale |
CHAMBERS REBECCA |
Chief Financial Officer | 166.03K | Sale |
EPSTEIN ROBERT S |
Director | 57.72K | Stock Award(Grant) |
FEBBO PHILLIP G |
Officer | 133.05K | Sale |
HAAS KEVIN RICHARD |
Officer | 44.22K | Stock Award(Grant) |
LEITE JOHN |
Officer | 124.33K | Sale |
MCGUIRE ANNIE |
General Counsel | 131.16K | Sale |
STAPLEY MARC A |
Chief Executive Officer | 440.49K | Sale |
WYGANT JONATHAN |
Officer | 45.43K | Sale |
Fundamentals
Market cap$3.59B
Enterprise value$3.14B
Revenue (TTM)$561.90M
Gross profit$414.44M
EBITDA$113.52M
Net income$114.48M
EPS (TTM)$1.31
Free cash flow$106.23M
Total cash$485.23M
Total debt$40.11M
Book value / share$17.28
Shares outstanding80.39M
Float79.88M
Short % of float12.35%
Dividend yield0.00%
Beta (5Y)1.95
Valuation & profitability ratios
Trailing P/E34.08
Forward P/E22.90
PEG ratio—
Price / sales—
Price / book2.58
EV / revenue5.60
EV / EBITDA27.70
Gross margin73.76%
Operating margin15.29%
Profit margin20.37%
Return on equity8.77%
Return on assets4.09%
Debt / equity2.89
Current ratio9.16
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $517.14M | $445.76M | $361.05M | $296.54M | +16.0% |
| Operating revenue | $517.14M | $445.76M | $361.05M | $296.54M | +16.0% |
| Cost of revenue | $154.61M | $147.62M | $131.37M | $120.86M | +4.7% |
| Gross profit | $362.53M | $298.14M | $229.68M | $175.68M | +21.6% |
| Research & development | $70.81M | $69.29M | $57.30M | $40.60M | +2.2% |
| Selling, general & admin | $210.95M | $206.04M | $187.72M | $170.76M | +2.4% |
| Total operating expense | $284.25M | $278.63M | $247.13M | $211.02M | +2.0% |
| Operating income | $78.28M | $19.51M | -$17.45M | -$35.34M | +301.2% |
| Net interest income | $12.72M | $11.15M | $7.33M | $1.77M | +14.1% |
| Pre-tax income | $68.20M | $25.74M | -$76.61M | -$36.43M | +164.9% |
| Tax provision | $1.85M | $1.61M | -$2.21M | $133.00K | +15.1% |
| Net income | $66.35M | $24.14M | -$74.40M | -$36.56M | +174.9% |
| Net income to common | $66.35M | $24.14M | -$74.40M | -$36.56M | +174.9% |
| Basic EPS | 0.84 | 0.32 | -1.02 | -0.51 | +162.5% |
| Diluted EPS | 0.82 | 0.31 | -1.02 | -0.51 | +164.5% |
| EBIT | $68.20M | $25.75M | -$76.60M | -$36.23M | +164.9% |
| EBITDA | $89.62M | $49.20M | -$49.41M | -$10.30M | +82.1% |
| Basic shares | 78.58M | 76.48M | 72.64M | 71.55M | +2.7% |
| Diluted shares | 80.57M | 78.16M | 72.64M | 71.55M | +3.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $362.58M | $239.09M | $216.45M | $154.25M | — | +51.7% |
| Cash & short-term investments | $412.89M | $289.44M | $216.45M | $178.85M | — | +42.7% |
| Accounts receivable | $44.66M | $46.52M | $40.38M | $44.02M | — | -4.0% |
| Inventory | $20.55M | $21.75M | $16.13M | $14.29M | — | -5.5% |
| Total current assets | $488.38M | $372.27M | $285.62M | $248.64M | — | +31.2% |
| Property, plant & equipment | $58.79M | $71.14M | $30.86M | $30.86M | — | -17.4% |
| Goodwill & intangibles | $856.30M | $848.10M | $791.58M | $870.76M | — | +1.0% |
| Total assets | $1.41B | $1.30B | $1.11B | $1.16B | — | +8.2% |
| Total current liabilities | $59.94M | $78.63M | $61.24M | $62.61M | — | -23.8% |
| Current debt | — | — | — | — | $1.13M | — |
| Total debt | $39.65M | $50.74M | $12.63M | $14.72M | — | -21.8% |
| Total liabilities | $96.44M | $124.07M | $70.80M | $81.22M | — | -22.3% |
| Retained earnings | -$377.63M | -$443.98M | -$468.12M | -$393.72M | — | +14.9% |
| Shareholder equity | $1.31B | $1.18B | $1.04B | $1.08B | — | +11.4% |
| Working capital | $428.44M | $293.63M | $224.38M | $186.02M | — | +45.9% |
| Net tangible assets | $453.27M | $327.87M | $252.53M | $204.44M | — | +38.3% |
| Shares issued | 79.36M | 77.77M | 73.26M | 71.96M | — | +2.0% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $66.35M | $24.14M | -$74.40M | -$36.56M | +174.9% |
| Depreciation & amortisation | $21.41M | $23.46M | $27.19M | $25.93M | -8.7% |
| Stock-based compensation | $43.60M | $36.25M | $33.14M | $26.73M | +20.3% |
| Change in working capital | -$2.30M | -$20.96M | -$3.69M | -$16.38M | +89.0% |
| Operating cash flow | $136.31M | $75.10M | $44.22M | $7.54M | +81.5% |
| Capital expenditure | -$9.68M | -$11.29M | -$9.96M | -$8.55M | +14.3% |
| Investing cash flow | -$9.21M | -$56.27M | $15.11M | -$29.39M | +83.6% |
| Financing cash flow | -$4.22M | $4.90M | $2.84M | $3.49M | -186.1% |
| Free cash flow | $126.63M | $63.81M | $34.26M | -$1.01M | +98.5% |
| End cash position | $364.23M | $240.63M | $217.33M | $155.00M | +51.4% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $150.32M | $139.07M | $140.64M | $131.87M | $130.16M | +8.1% |
| Operating revenue | $150.32M | $139.07M | $140.64M | $131.87M | $130.16M | +8.1% |
| Cost of revenue | $41.77M | $37.91M | $38.66M | $40.59M | $40.40M | +10.2% |
| Gross profit | $108.55M | $101.16M | $101.97M | $91.28M | $89.77M | +7.3% |
| Research & development | $29.44M | $27.10M | $20.85M | $15.98M | $16.26M | +8.7% |
| Selling, general & admin | $55.71M | $50.84M | $43.47M | $50.71M | $57.65M | +9.6% |
| Total operating expense | $85.57M | $78.51M | $62.06M | $68.17M | $74.53M | +9.0% |
| Operating income | $22.98M | $22.65M | $39.91M | $23.11M | $15.24M | +1.5% |
| Net interest income | $3.88M | $3.48M | $3.54M | $3.48M | $2.94M | +11.7% |
| Pre-tax income | $26.52M | $29.97M | $40.63M | $18.89M | $1.25M | -11.5% |
| Tax provision | $1.03M | $1.27M | -$515.00K | -$248.00K | $2.23M | -18.5% |
| Net income | $25.49M | $28.71M | $41.15M | $19.14M | -$980.00K | -11.2% |
| Net income to common | $25.49M | $28.71M | $41.15M | $19.14M | -$980.00K | -11.2% |
| Basic EPS | 0.32 | 0.36 | 0.52 | 0.24 | -0.01 | -11.1% |
| Diluted EPS | 0.31 | 0.35 | 0.51 | 0.24 | -0.01 | -11.4% |
| EBIT | $26.52M | $29.97M | $40.63M | $18.89M | $1.25M | -11.5% |
| EBITDA | $31.36M | $35.40M | $45.93M | $24.16M | $6.74M | -11.4% |
| Basic shares | 79.97M | 79.54M | 79.18M | 78.73M | 78.39M | +0.5% |
| Diluted shares | 82.06M | 81.31M | 81.39M | 79.69M | 78.39M | +0.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $299.52M | $263.14M | $362.58M | $315.57M | $219.50M | +13.8% |
| Cash & short-term investments | $485.23M | $439.06M | $412.89M | $366.43M | $320.72M | +10.5% |
| Accounts receivable | $54.18M | $50.11M | $44.66M | $47.83M | $50.81M | +8.1% |
| Inventory | $22.66M | $21.42M | $20.55M | $20.33M | $25.02M | +5.8% |
| Total current assets | $574.77M | $522.17M | $488.38M | $449.22M | $414.68M | +10.1% |
| Property, plant & equipment | $57.10M | $58.52M | $58.79M | $56.20M | $57.23M | -2.4% |
| Goodwill & intangibles | $849.85M | $853.02M | $856.30M | $859.63M | $869.06M | -0.4% |
| Total assets | $1.49B | $1.44B | $1.41B | $1.37B | $1.34B | +3.5% |
| Total current liabilities | $62.74M | $56.12M | $59.94M | $72.15M | $76.43M | +11.8% |
| Total debt | $40.11M | $39.33M | $39.65M | $40.45M | $50.65M | +2.0% |
| Total liabilities | $97.96M | $91.99M | $96.44M | $110.12M | $123.05M | +6.5% |
| Retained earnings | -$323.43M | -$348.92M | -$377.63M | -$418.78M | -$437.92M | +7.3% |
| Shareholder equity | $1.39B | $1.34B | $1.31B | $1.26B | $1.22B | +3.3% |
| Working capital | $512.04M | $466.06M | $428.44M | $377.07M | $338.25M | +9.9% |
| Net tangible assets | $538.55M | $491.39M | $453.27M | $398.04M | $352.00M | +9.6% |
| Shares issued | 80.36M | 79.79M | 79.36M | 79.03M | 78.60M | +0.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $25.49M | $28.71M | $41.15M | $19.14M | -$980.00K | -11.2% |
| Depreciation & amortisation | $4.84M | $5.43M | $5.30M | $5.27M | $5.49M | -10.9% |
| Stock-based compensation | $14.09M | $12.76M | $10.90M | $10.76M | $10.98M | +10.4% |
| Change in working capital | $1.74M | -$11.73M | $5.48M | $4.45M | $2.27M | +114.8% |
| Operating cash flow | $45.83M | $35.22M | $52.58M | $44.76M | $33.60M | +30.1% |
| Capital expenditure | -$2.86M | -$2.96M | -$3.78M | -$2.79M | -$1.29M | +3.5% |
| Investing cash flow | -$13.54M | -$127.96M | -$5.43M | $48.26M | -$224.00K | +89.4% |
| Financing cash flow | $4.14M | -$6.63M | -$149.00K | $2.98M | -$566.00K | +162.4% |
| Free cash flow | $42.97M | $32.25M | $48.80M | $41.97M | $32.32M | +33.2% |
| End cash position | $301.19M | $264.79M | $364.23M | $317.21M | $221.15M | +13.7% |
Options analytics
Put / call volume
16.08
Put-heavy session
Put / call open interest
7.35
Positioning, not flow
Max pain
45.00
+0.8% from spot
ATM implied vol
58.1%
Nearest strike to spot
Skew (10% OTM)
-53.9%
Calls bid over puts
Call volume
63
Contracts, this expiry
Put volume
1.01K
Contracts, this expiry
Heaviest call OI
60.00
78 contracts
Heaviest put OI
40.00
1.00K contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.43 | 0.54 | +25.1% |
| Mar 2026 | 0.33 | 0.52 | +56.0% |
| Dec 2025 | 0.41 | 0.53 | +29.8% |
| Sep 2025 | 0.32 | 0.51 | +59.5% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.41 | 12 | $147.16M | +11.6% |
| Next quarter | 0.45 | 12 | $157.29M | +11.8% |
| Current year | 1.91 | 12 | $593.69M | +14.8% |
| Next year | 1.95 | 12 | $660.27M | +11.2% |
Analyst targets & ownership
Mean target$58.42
High target$70.00
Low target$44.00
Implied upside30.07%
Analyst count12
ConsensusBUY
Strong buy / Buy2 / 9
Hold1
Sell / Strong sell1 / 0
Held by insiders0.49%
Held by institutions112.35%
Institutions holding514
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
45.75
-1.83% from price
SMA 20
43.47
+2.72% from price
SMA 50
44.55
+0.23% from price
SMA 100
48.36
-7.14% from price
SMA 200
42.54
+4.95% from price
EMA 12
44.96
-0.12% from price
EMA 26
44.48
+0.97% from price
EMA 50
45.22
-0.68% from price
RSI (14)
50.4
Neutral
MACD (12,26,9)
0.49
Hist 0.45
ATR (14)
2.74
6.13% of price
Realised vol 30D
62.5%
Annualised
Bollinger upper
48.88
20, 2σ
Bollinger lower
38.05
20, 2σ
50 / 200 cross
Golden
44.55 vs 42.54
Trend bias
Above 200
+4.95%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.42
More volatile than market
Correlation to SPY
0.28
Largely independent
Realised vol 30D
62.5%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-39.2%
Peak to trough
Max drawdown 5Y
-71.5%
Peak to trough
ATR 14
2.74
6.13% of price
Beta (reported)
1.95
5Y monthly, from filing
Short interest
Shares short
8.40M
Prior 6.79M
Change vs prior
+23.8%
Shorts adding
% of float
12.35%
Elevated
% of shares out
10.45%
Against total outstanding
Days to cover
6.7
Crowded exit
Float
79.88M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 15, 26 | Freedom Capital Markets | MAINTAINED | Buy | Buy |
| Sep 9, 26 | UBS | MAINTAINED | Buy | Buy |
| Aug 4, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Aug 4, 26 | Stephens & Co. | MAINTAINED | Overweight | Overweight |
| Aug 4, 26 | Morgan Stanley | MAINTAINED | Underweight | Underweight |
| Aug 3, 26 | Canaccord Genuity | MAINTAINED | Hold | Hold |
| Jul 31, 26 | Needham | MAINTAINED | Buy | Buy |
| Jul 30, 26 | Needham | MAINTAINED | Buy | Buy |
| Jul 15, 26 | Piper Sandler | INITIATED | Overweight | Overweight |
| Jul 14, 26 | Canaccord Genuity | MAINTAINED | Hold | Hold |
| Jul 9, 26 | Morgan Stanley | MAINTAINED | Underweight | Underweight |
| Jun 29, 26 | Guggenheim | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-14
Periodic Financial Reports
10-Q · 2026-07-31
Corporate Changes & Voting Matters
8-K · 2026-07-30
Corporate Changes & Voting Matters
8-K · 2026-06-11
Offering Registrations
S-8 · 2026-06-10
Periodic Financial Reports
10-Q · 2026-05-06
Corporate Changes & Voting Matters
8-K · 2026-05-05
Proxy Statements
DEF 14A · 2026-04-22
Headlines
Is It Prudent to Add Teleflex Stock to Your Portfolio Now?
Zacks · 12h ago
Cathie Wood Loads Up On These Biotech Stocks After Strong Rallies – Unloads $18M Worth Of TWST Shares
Stocktwits · 14h ago
Cathie Wood Reworks Major Nvidia-AMD Position
GuruFocus.com · 1d ago
Veeva's OpenData to Help Servier Build a Global AI Data Foundation
Zacks · 1d ago
Veracyte (VCYT) Could Be 22% Undervalued After New Decipher Phase III Data
Simply Wall St. · 4d ago
Veracyte (VCYT) Is Down 9.0% After New Level 1B1 Decipher Prostate Data at ASTRO 2026
Simply Wall St. · 5d ago
Could Veracyte (VCYT) Change Prostate Cancer Care With New Phase III Data?
Simply Wall St. · 5d ago
Neogen Stock Rallies 83% YTD: What's Driving the Surge?
Zacks · 6d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.